This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Ahn-Gook Pharmaceutical Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Ho-Young Kwak: Innovator in Pharmaceutical Composition for Nephritis Treatment
Introduction
Ho-Young Kwak is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of nephritis. His innovative approach utilizes herbal extracts, showcasing the potential of natural remedies in modern medicine.
Latest Patents
Ho-Young Kwak holds a patent for a pharmaceutical composition containing herbal extracts aimed at preventing or treating nephritis. This invention highlights the novel use of herbal extracts, including Crataegi Fructus extract, Cinnamomi Cortex extract, Prunella Spica extract, and Equiseti Herba extract. The composition demonstrates a therapeutic effect on nephritis, particularly in models induced by drugs such as gentamicin and cisplatin. The herbal extracts also exhibit inhibitory activity on the growth of mesangial cells in the kidneys, providing a promising avenue for nephritis treatment.
Career Highlights
Kwak is associated with Ahn-gook Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to integrating traditional herbal medicine with contemporary pharmaceutical practices.
Collaborations
He collaborates with esteemed colleagues, including Jin Auh and Chang-Hwan Kim, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Ho-Young Kwak's innovative contributions to nephritis treatment through herbal extracts exemplify the intersection of traditional medicine and modern science. His work not only addresses a critical health issue but also opens new pathways for future research and development in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile